9,10-dimethyl-1,2-benzanthracene has been researched along with nimbolide in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kumar, GH; Manikandan, P; Nagini, S; Priyadarsini, RV | 1 |
Harish Kumar, G; Nagini, S; Vidjaya Letchoumy, P; Vidya Priyadarsini, R; Vinothini, G | 1 |
2 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and nimbolide
Article | Year |
---|---|
The neem limonoids azadirachtin and nimbolide inhibit hamster cheek pouch carcinogenesis by modulating xenobiotic-metabolizing enzymes, DNA damage, antioxidants, invasion and angiogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Antioxidants; Base Sequence; Cheek; Cricetinae; DNA Damage; DNA Primers; Enzymes; Free Radical Scavengers; In Vitro Techniques; Limonins; Male; Mesocricetus; Mouth Mucosa; Neoplasm Invasiveness; Neoplasms, Experimental; Neovascularization, Pathologic; Xenobiotics | 2009 |
The neem limonoids azadirachtin and nimbolide inhibit cell proliferation and induce apoptosis in an animal model of oral oncogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Azadirachta; Cell Cycle Proteins; Cell Proliferation; Cricetinae; Disease Models, Animal; Drug Screening Assays, Antitumor; Limonins; Male; Mouth Neoplasms; Random Allocation | 2010 |